A comprehensive evaluation of the proficiency testing program for the HIV-1 BED incidence assay

Journal of Clinical Microbiology

Volumn 49, Issue 10, 2011, Pages 3470-3473

  Dobbs, Trudy ^a   Liu, Xin ^a   Anderson, Rebecca ^a   Nkengasong, John ^a   Parekh, Bharat S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL EQUIPMENT; ANALYTICAL ERROR; ARTICLE; CALIBRATION; CONTROLLED STUDY; DISEASE SURVEILLANCE; ENZYME IMMUNOASSAY; EVALUATION RESEARCH; GOOD LABORATORY PRACTICE; HIV 1 BED INCIDENCE ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INCIDENCE; LABORATORY DIAGNOSIS; OPTICAL DENSITY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; REPRODUCIBILITY; SCORING SYSTEM; VIRUS DETECTION;

CLINICAL LABORATORY TECHNIQUES; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; INCIDENCE; OBSERVER VARIATION; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80053463928     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01122-11     Document Type: Article

References (30)

1. Barin, F., et al. 2005. Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots. J. Clin. Microbiol. 43:4441-4447. (Pubitemid 41298225)
2. Cha, Y. J., and H. I. Cho. 2002. External quality assurance in diagnostic immunology: a twenty-year experience in Korea. Southeast Asian J. Trop. Med. Public Health 33(Suppl. 2):104-111.
3. Chalermchan, W., S. Pitak, and S. Sungkawasee. 2007. Evaluation of Thailand national external quality assessment on HIV testing. Int. J. Health Care Quality Assurance 20:130-140.
4. Constantine, N. T., et al. 2003. Improved classification of recent HIV-1 infection by employing a two-stage sensitive/less-sensitive test strategy. J. Acquir. Immune Defic. Syndr. 32:94-103. (Pubitemid 36091491)
5. Demmler, G. J., A. Istas, K. A. Easley, and A. Kovacs. 2000. Results of a quality assurance program for detection of cytomegalovirus infection in the pediatric pulmonary and cardiovascular complications of vertically transmitted human immunodeficiency virus infection study. J. Clin. Microbiol. 38:3942-3945. (Pubitemid 32233186)
6. Dhingra-Kumar, N., A. K. Sharma, and N. Madan. 1997. Analysis of quality assurance programmes for HIV screening in blood transfusion centres in Delhi. Bull. World Health Organ. 75:223-228. (Pubitemid 27373561)
7. Dobbs, T., S. Kennedy, C. P. Pau, J. S. McDougal, and B. S. Parekh. 2004. Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J. Clin. Microbiol. 42:2623-2628. (Pubitemid 38747513)
8. Hall, H. I., et al. 2008. Estimation of HIV incidence in the United States. JAMA 300:520-529.
9. Hannon, W. H., D. S. Lewis, W. K. Jones, and M. K. Powell. 1989. A quality assurance program for human immunodeficiency virus seropositivity screening of dried-blood spot specimens. Infect. Control Hosp. Epidemiol. 10:8-13.
10. Hargrove, J. W., et al. 2008. Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS 22:511-518. (Pubitemid 351317293)
11. Hu, D. J., et al. 2003. HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay. AIDS Res. Hum. Retrovir. 19:727-730. (Pubitemid 37215127)
12. Jackson, J. B., et al. 1993. Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group. J. Clin. Microbiol. 31:3123-3128. (Pubitemid 23335596)
13. Janssen, R. S., et al. 1998. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 280:42-48. (Erratum, 281:1893, 1999.)
14. Jenner, J., M. Grazioplene, A. Kazianis, K. Phinney, and B. Werner. 2003. Modification of a commercial HIV-1 enzyme immunoassay for identification of recent HIV-1 infections: use of differential antibody avidity, abstr. 653. Tenth Conference on Retroviruses and Opportunistic Infections, Boston, MA.
15. Jiang, Y., et al. 2007. HIV-1 incidence estimates using IgG-capture BEDenzyme immunoassay from surveillance sites of injection drug users in three cities of China. AIDS 21(Suppl. 8):S47-S51.
16. Kim, A., et al. 2010. Evaluating the BED capture enzyme immunoassay to estimate HIV incidence among adults in three countries in sub-Saharan Africa. AIDS Res. Hum. Retrovir. 28:1051-1061.
17. Kothe, D., et al. 2003. Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J. Acquir. Defic. Syndr. 33:625-634. (Pubitemid 36975851)
18. Masciotra, S., et al. 2010. Antibody avidity-based assay for identifying recent HIV-1 infections based on Genetic Systems TM1/2 Plus O EIA, abstr. 937. 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA.
19. Nesheim, S., et al. 2005. Temporal trends in HIV type 1 incidence among inner-city childbearing women in Atlanta: use of the IgG-capture BEDenzyme immunoassay. AIDS Res. Hum. Retrovir. 21:537-544. (Pubitemid 40944315)
20. Parekh, B., et al. 2010. Dried tube specimens: a simple and cost-effective method for preparation of HIV proficiency testing panels and quality control materials for use in resource-limited settings. J. Virol. Methods 163:295-300.
21. Parekh, B., et al. 2007. Development of a limiting-antigen avidity-based enzyme immunoassay using a chimeric recombinant gp41 protein to detect recent HIV-1 infection, abstr. 342. 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, CA.
22. Parekh, B. S. 2005. Use of dried blood spots (DBS) or dried serum/plasma spots (DSS/DPS) to detect recent HIV-1 seroconversion by the BED-CEIA. HIV Diagnostics: New Developments and Challenges, Orlando, FL.
23. Parekh, B. S., et al. 2002. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res. Hum. Retrovir. 18:295-307. (Pubitemid 34253148)
24. Parekh, B. S., C. P. Pau, M. S. Kennedy, T. L. Dobbs, and J. S. McDougal. 2001. Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection. AIDS Res. Hum. Retrovir. 17:137-146. (Pubitemid 32099298)
25. Rawal, B. D., et al. 2003. Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection. J. Acquir. Immune Defic. Syndr. 33:349-355. (Pubitemid 36859061)
26. Saphonn, V., et al. 2005. Trends of HIV seroincidence among HIV sentinel surveillance groups in Cambodia, 1999-2002. J. Acquir. Immune Defic. Syndr. 39:587-592. (Pubitemid 41098475)
27. Soroka, S. D., T. C. Granade, D. Candal, and B. S. Parekh. 2005. Modification of rapid human immunodeficiency virus (HIV) antibody assay protocols for detecting recent HIV seroconversion. Clin. Diagn. Lab. Immunol. 12:918-921.
28. Suligoi, B., et al. 2002. Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J. Clin. Microbiol. 40:4015-4020. (Pubitemid 35285783)
29. Wei, X., et al. 2010. Development of two avidity based assays to detect recent HIV-1 seroconversion using a multi-subtype gp41 recombinant protein. AIDS Res. Hum. Retrovir. 26:61-71.
30. Wilson, K. M., et al. 2004. Incidence immunoassay for distinguishing recent from established HIV-1 infection in therapy-naive populations. AIDS 18: 2253-2259. (Pubitemid 39620217)